Author Topic: Coronavirus: Study casts doubt on herd immunity feasibility  (Read 84 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
From BBC News (July 7, 2020)--"Coronavirus: Spanish Study Casts Doubt on Herd Immunity Feasibility":


https://bbc.in/2DCbabP
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Herd immunity and implications for SARS-CoV-2 control
« Reply #1 on: October 20, 2020, 08:43:01 pm »
From JAMA "Insights" (October 19, 2020),  this article by researchers at Yale University--"Herd immunity and implications for SARS-CoV-2 control":



https://bit.ly/3jbywEc


The article contains this:


Quote
Assuming that less than 10% of the population has been infected so far, with an infection-induced immunity lasting 2 to 3 years (duration unknown), infection-induced herd immunity is not realistic at this point to control the pandemic. SARS-CoV-2 vaccines will help to reach the herd immunity threshold, but the effectiveness of the vaccine(s) and the vaccine coverage are to be seen.
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
4 Replies
118 Views
Last post March 01, 2020, 07:32:19 am
by agate
1 Replies
68 Views
Last post March 09, 2020, 08:05:29 pm
by agate
1 Replies
65 Views
Last post April 12, 2020, 09:04:25 pm
by agate
0 Replies
48 Views
Last post April 02, 2021, 09:24:09 pm
by agate
2 Replies
75 Views
Last post November 03, 2021, 09:41:33 pm
by agate